The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
The transcriptional role of PML and the nuclear body
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
The Bloom's syndrome gene product is homologous to RecQ helicases
Ellis, N. A., Groden, J., Ye, T.-Z., Straughen, J., Lennon, D. J., Ciocci, S., Proytcheva, M., & German, J. (1995) · Cell · doi:10.1016/0092-8674(95)90105-1 · Cited by 1,403
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 930
Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3
Saitoh, H., & Hinchey, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6252 · Cited by 895
Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 832
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
A new protease required for cell-cycle progression in yeast
Li, S.-J., & Hochstrasser, M. (1999) · Nature · doi:10.1038/18457 · Cited by 737
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
Rachez, C., Lemon, B. D., Suldan, Z., Bromleigh, V., Gamble, M., Näär, A. M., Erdjument-Bromage, H., Tempst, P., & Freedman, L. P. (1999) · Nature · doi:10.1038/19783 · Cited by 729
Regulation of activity of the transcription factor GATA-1 by acetylation
Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V. (1998) · Nature · doi:10.1038/25166 · Cited by 694
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.
Fondell, J. D., Ge, H., & Roeder, R. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8329 · Cited by 578
Role of SUMO-1–modified PML in nuclear body formation
Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., & Pandolfi, P. P. (2000) · Blood · doi:10.1182/blood.v95.9.2748.009k31a_2748_2752 · Cited by 561
Self-citationPml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
Self-citationA novel gysteine-rich sequence motif
Freemont, P. S., Hanson, I. M., & Trowsdale, J. (1991) · Cell · doi:10.1016/0092-8674(91)90229-r · Cited by 543
Role of PML in Cell Growth and the Retinoic Acid Pathway
Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., & Paolo Pandolfi, P. (1998) · Science · doi:10.1126/science.279.5356.1547 · Cited by 517
BUSCH, H. (1966) · Nature · doi:10.1038/2111347a0 · Cited by 515
Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M., & Del Sal, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6462 · Cited by 513
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Everett, R. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 492
The RING finger domain: a recent example of a sequence—structure family
Borden, K. L., & Freemont, P. S. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80060-1 · Cited by 470
Matunis, M. J., Wu, J., & Blobel, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.499 · Cited by 464
Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia
Goddard, A. D., Borrow, J., Freemont, P. S., & Solomon, E. (1991) · Science · doi:10.1126/science.1720570 · Cited by 458
Composite co-activator ARC mediates chromatin-directed transcriptional activation
Näär, A. M., Beaurang, P. A., Zhou, S., Abraham, S., Solomon, W., & Tjian, R. (1999) · Nature · doi:10.1038/19789 · Cited by 429
Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05095.x · Cited by 415
PML induces a novel caspase-independent death process
Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J.-C., & de Thé, H. (1998) · Nature Genetics · doi:10.1038/3068 · Cited by 374
Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML
Li, H., Leo, C., Zhu, J., Wu, X., O'Neil, J., Park, E.-J., & Chen, J. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1784-1796.2000 · Cited by 364
Blobel, G. A., Nakajima, T., Eckner, R., Montminy, M., & Orkin, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2061 · Cited by 355
Boddy, M. N., Howe, K. M., Etkin, L. D., Solomon, E., & Freemont, P. S. (1996) · PubMed · Cited by 348
Zhang, Y., & Xiong, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80351-2 · Cited by 348
Zhang, W., & Bieker, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9855 · Cited by 342
Insights into the functions of BRCA1 and BRCA2
Welcsh, P. L., Owens, K. N., & King, M.-C. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01930-7 · Cited by 335
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition.
Ishov, A. M., & Maul, G. G. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.4.815 · Cited by 333
Sternsdorf, T., Jensen, K., & Will, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1621 · Cited by 331
Borden, K. L., Boddy, M. N., Lally, J., O'Reilly, N. J., Martin, S., Howe, K., Solomon, E., & Freemont, P. S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07139.x · Cited by 328
Identification of Three Major Sentrinization Sites in PML
Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26675 · Cited by 310
Pandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo‐Coco, F., Grignani, F., & Pelicci, P. G. (1991) · PubMed · Cited by 305
Self-citationMüller, S., & Dejean, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5137-5143.1999 · Cited by 304
PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
Identification of a novel nuclear domain.
Ascoli, C. A., & Maul, G. G. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.5.785 · Cited by 285
Differential Regulation of Sentrinized Proteins by a Novel Sentrin-specific Protease
Gong, L., Millas, S., Maul, G. G., & Yeh, E. T. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3355 · Cited by 279
Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA
Boisvert, F.-M., Hendzel, M. J., & Bazett-Jones, D. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.283 · Cited by 276
Seeler, J.-S., Marchio, A., Sitterlin, D., Transy, C., & Dejean, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7316 · Cited by 274
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
Torii, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6037 · Cited by 272
Stadler, M., Chelbi‐Alix, M. K., Koken, M. H. M., Venturini, L., Lee, C., Saı̈b, A., Quignon, F., Pelicano, L., Guillemin, M.-C., & Schindler, C. (1995) · PubMed · Cited by 266
Sternsdorf, T., Jensen, K., Reich, B., & Will, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12555 · Cited by 264
Ahn, J. H., & Hayward, G. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4599-4613.1997 · Cited by 247
Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis
Zhong, S., Salomoni, P., Ronchetti, S., Guo, A., Ruggero, D., & Pandolfi, P. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.631 · Cited by 244
Self-citationLocalization of nascent RNA and CREB binding protein with the PML-containing nuclear body
LaMorte, V. J., Dyck, J. A., Ochs, R. L., & Evans, R. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4991 · Cited by 239
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
A role for PML and the nuclear body in genomic stability
Zhong, S., Hu, P., Ye, T.-Z., Stan, R., Ellis, N. A., & Pandolfi, P. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203367 · Cited by 230
Self-citationResistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein
Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. M., & de Thé, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1043-1051.1998 · Cited by 229
The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau, C., Marchio, A., Fagioli, M., Jansen, J. H., Falini, B., Lebon, P., Grosveld, F. G., Pandolfi, P. P., Pelicci, P. G., & Dejean, A. (1995) · PubMed · Cited by 228
Self-citationMolecular genetics of Bloom's syndrome
Ellis, N. A., & German, J. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1457 · Cited by 195
Structure, Organization, and Dynamics of Promyelocytic Leukemia Protein Nuclear Bodies
Hodges, M., Tissot, C., Howe, K., Grimwade, D., & Freemont, P. S. (1998) · The American Journal of Human Genetics · doi:10.1086/301991 · Cited by 177
Ahn, J.-H., Brignole, E. J., & Hayward, G. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4899 · Cited by 175
Chromatin components as part of a putative transcriptional repressing complex
Lehming, N., Le Saux, A., Schüller, J., & Ptashne, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7322 · Cited by 175
Doucas, V., Tini, M., Egan, D. A., & Evans, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2627 · Cited by 170
PML nuclear bodies are general targets for inflammation and cell proliferation.
Terris, B., Baldin, V., Dubois, S., Degott, C., Fléjou, J., Hénin, D., & Dejean, A. (1995) · PubMed · Cited by 163
The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein
Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K., & Pelicci, P. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1084 · Cited by 161
Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells.
Johnson, F. B., Lombard, D. B., Neff, N. F., Mastrangelo, M.-A. A., DeWolf, W. C., Ellis, N. A., Marciniak, R. A., Yin, Y., Jaenisch, R., & Guarente, L. (2000) · PubMed · Cited by 160
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis
Guldner, H. H., Szostecki, C., Grötzinger, T., & Will, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.4067 · Cited by 156
Molecular Cloning of a New Interferon-induced PML Nuclear Body-associated Protein
Gongora, C., David, G., Pintard, L., Tissot, C., Hua, T. D., Dejean, A., & Mechti, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19457 · Cited by 153
Nuclear dots: Actors on Many Stages
Sternsdorf, T., Grötzinger, T., Jensen, K., & Will, H. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80051-4 · Cited by 143
Asano, K., Merrick, W. C., & Hershey, J. W. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23477 · Cited by 142
Laín, S., Midgley, C., Sparks, A., Lane, E. B., & Lane, D. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4433 · Cited by 136
Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System
Swindle, C. S., Zou, N., Tine, B. A. V., Shaw, G. M., Engler, J. A., & Chow, L. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1001-1009.1999 · Cited by 127
Zhong, S., Delva, L., Rachez, C., Cenciarelli, C., Gandini, D., Zhang, H., Kalantry, S., Freedman, L. P., & Pandolfi, P. P. (1999) · Nature Genetics · doi:10.1038/15463 · Cited by 126
Self-citationAnalysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML
Le, X., Yang, P., & Chang, K.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.130 · Cited by 126
Everett, R. D., Meredith, M., & Orr, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.417-426.1999 · Cited by 122
A viral activator of gene expression functions via the ubiquitin–proteasome pathway
Everett, R. D., Orr, A., & Preston, C. M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7161 · Cited by 116
Identification and Characterization of a Leukocyte-specific Component of the Nuclear Body
Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A., & Bloch, K. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29198 · Cited by 103
He, L.-Z., Merghoub, T., & Pandolfi, P. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203088 · Cited by 102
Self-citationLai, H.-K., & Borden, K. L. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203473 · Cited by 99
The putative nuclear receptor mediator TIF1α is tightly associated with euchromatin
Remboutsika, E., Lutz, Y., Gansmüller, A., Vonesch, J., Losson, R., & Chambon, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.11.1671 · Cited by 98
Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein
Vallian, S., Gäken, J. A., Gingold, E. B., Kouzarides, T., Chang, K.-S., & Farzaneh, F. (1998) · Oncogene · doi:10.1038/sj.onc.1201837 · Cited by 54
Transcriptional Repression by the Promyelocytic Leukemia Protein, PML
Vallian, S., Gäken, J. A., Trayner, I. D., Gingold, E. B., Kouzarides, T., Chang, K.-S., & Farzaneh, F. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3801 · Cited by 48
Gaboli, M. P., Gandini, D., Delva, L., Wang, Z., & Pandolfi, P. P. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809050925 · Cited by 34
Self-citationHuman T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling.
Doucas, V., & Evans, R. M. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.6.2633 · Cited by 27
Cited by
The tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
p300/CBP proteins: HATs for transcriptional bridges and scaffolds
Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092
FOXOs: signalling integrators for homeostasis maintenance
Eijkelenboom, A., & Burgering, B. M. T. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3507 · Cited by 1,080
Nuclear structure in cancer cells
Zink, D., Fischer, A. H., & Nickerson, J. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1430 · Cited by 1,068
Metadata
- Authors
- Zhong, S., Salomoni, P., & Pandolfi, P. P.
- Venue
- Nature Cell Biology
- Published
- 2000-05
- Volume
- 2
- Issue
- 5
- Pages
- E85-E90
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1556421650
- Cited by
- 577
- References
- 85
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.